Krishnan, M., & Babu, S. Harnessing programmed death-ligand 1 as a prognostic marker in OSCC: Challenges and opportunities in the era of immunotherapy. Elsevier.
Chicago Style (17th ed.) CitationKrishnan, Madhan, and Shyamaladevi Babu. Harnessing Programmed Death-ligand 1 as a Prognostic Marker in OSCC: Challenges and Opportunities in the Era of Immunotherapy. Elsevier.
MLA (9th ed.) CitationKrishnan, Madhan, and Shyamaladevi Babu. Harnessing Programmed Death-ligand 1 as a Prognostic Marker in OSCC: Challenges and Opportunities in the Era of Immunotherapy. Elsevier.
Warning: These citations may not always be 100% accurate.